Modulus 1091348P2Recalls & reported problems
Nuvasive, Inc. · Modulus TLIF-A, 9x11x34mm 8° · Class 2 · Implant
All models of Modulus (41)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00887517849496), received between Feb 19, 2025 and Feb 19, 2025 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Detachment of Device or Device Component1
Patient problems
- Bacterial Infection1
- Pain1
- Wound Dehiscence1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 19, 2025Detachment of Device or Device Component; Detachment of Device or Device Component
THE EVENT WAS IDENTIFIED DURING A REVIEW OF THE LIB COMPLICATIONS STUDY, THE REPORT IDENTIFIED THAT ON (B)(6) 2022 A PATIENT UNDERWENT A TWO LEVEL TRANSFORAMINAL LUMBAR INTERBODY FUSION PROCEDURE AT L4/5 AND L5/S1 WITH POSTERIOR FIXATION FROM T10 TO PELVIS. DURING THE PROCEDURE A SMALL DUROTOMY WAS ENCOUNTERED AT THE RIGHT L5-S1 HEMILAMINECTOMY SITE WHICH WAS REPAIRED WITH NUROLON AND SURASEAL. (B)(6) ON (B)(6) 2022, WHEN FINAL HEMOVAC DRAIN WAS REMOVED, INCREASE DRAINAGE FROM SITE WAS NOTED AND A TESTED SAMPLE OF FLUID WAS POSITIVE FOR TAU. SKIN SURROUNDING INCISION DEVELOPED BULLAE. MIDODRINE STARTED FOR PERIOPERATIVE HYPOTENSION. STOPPED ON POD 8 WITH THE PLAN TO RESTART HOME HORMONE SUPPLEMENT. PATIENT ENDORSED HER BLOOD PRESSURE IS HIGHER WHEN TAKING SUPPLEMENTS. PATIENT PLANS TO FOLLOW UP WITH PCP REGARDING HORMONES AND BLOOD PRESSURE MEDICATION. ON (B)(6) 2022, PATIENT CALLED IN TO NEUROSURGERY ON CALL SERVICE REPORTING SMALL AREA OF DEHISCENCE W/ YELLOW DRAINAGE. PATIENT SCHEDULED TO BE SEEN IN CLINIC ON (B)(6) 2023 VISIT SMALL DEHISCENCE W/ NO DRAINAGE. TREATED WITH KEFLEX, HOME HEALTH WOUND CARE W/ SILVER ALGINATE DRESSING. (B)(6). ON (B)(6) 2023, AT 6MO PO VISIT; PATIENT
Patient problems: Pain
MAUDE report 21415620 ↗InjuryFeb 19, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE EVENT WAS IDENTIFIED DURING A REVIEW OF THE LIB COMPLICATIONS STUDY, THE REPORT IDENTIFIED THAT ON (B)(6) 2022 A PATIENT UNDERWENT A TWO LEVEL TRANSFORAMINAL LUMBAR INTERBODY FUSION PROCEDURE AT L4/5 AND L5/S1 WITH POSTERIOR FIXATION FROM T10 TO PELVIS. DURING THE PROCEDURE A SMALL DUROTOMY WAS ENCOUNTERED AT THE RIGHT L5-S1 HEMILAMINECTOMY SITE WHICH WAS REPAIRED WITH NUROLON AND SURASEAL. (B)(6). ON (B)(6) 2022 WHEN FINAL HEMOVAC DRAIN WAS REMOVED, INCREASE DRAINAGE FROM SITE WAS NOTED AND A TESTED SAMPLE OF FLUID WAS POSITIVE FOR TAU. SKIN SURROUNDING INCISION DEVELOPED BULLAE. MIDODRINE STARTED FOR PERIOPERATIVE HYPOTENSION. STOPPED ON POD 8 WITH THE PLAN TO RESTART HOME HORMONE SUPPLEMENT. PATIENT ENDORSED HER BLOOD PRESSURE IS HIGHER WHEN TAKING SUPPLEMENTS. PATIENT PLANS TO FOLLOW UP WITH PCP REGARDING HORMONES AND BLOOD PRESSURE MEDICATION. ON (B)(6) 2022 PATIENT CALLED IN TO NEUROSURGERY ON CALL SERVICE REPORTING SMALL AREA OF DEHISCENCE W/ YELLOW DRAINAGE. PATIENT SCHEDULED TO BE SEEN IN CLINIC ON (B)(6) 2023 VISIT SMALL DEHISCENCE W/ NO DRAINAGE. TREATED WITH KEFLEX, HOME HEALTH WOUND CARE W/ SILVER ALGINATE DRESSING.
Patient problems: Bacterial Infection; Wound Dehiscence
MAUDE report 21414976 ↗
Other Intervertebral fusion device with bone graft, lumbar devices
- T-PAL 03.812.003Synthes GmbH · Intervertebral fusion device with bone graft, lumbar152 reports
- T-PAL 03.812.004Synthes GmbH · Intervertebral fusion device with bone graft, lumbar120 reports
- Catalyft PL Expandable Interbody System 6068073Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall66 reports
- Catalyft PL Expandable Interbody System 6069076Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall51 reports
- Catalyft PL Expandable Interbody System 6068076Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall46 reports
- EIT TLIF Inserter TFT30101EIT Emerging Implant Technologies GmbH · Intervertebral Fusion Device With Bone Graft, Lumbar88 reports
- T-PAL 03.812.001Synthes GmbH · Intervertebral fusion device with bone graft, lumbar76 reports
- Catalyft PL Expandable Interbody System 6069096Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall25 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page